Why XLV Remains the Ultimate Defensive ETF for Volatile Markets

The Health Care Select Sector SPDR Fund, known as XLV, has long been a favoured choice for investors seeking stability. This exchange-traded fund (ETF) tracks all healthcare stocks within the S&P 500, weighted by company size. As market swings grow sharper and tech stocks lose momentum, XLV often steps in as a defensive play.

The fund currently trades at under 18 times trailing earnings, a valuation many consider attractive for its steady performance. Healthcare now ranks as the sixth-largest sector in the S&P 500. XLV covers this broad industry, from pharmaceutical giants to medical device makers and insurance providers. Each sub-sector behaves differently: drug manufacturers rely on global demand and strong patent protections, while medical devices drive growth with higher volatility.

Insurance firms, often called cash-flow utilities, face constant exposure to government policies and reimbursement rules. Despite these risks, XLV maintains a beta of just 0.58, meaning it moves far less sharply than the wider market. This low volatility makes it a go-to option when uncertainty rises.

For investors managing their own portfolios, tools like the ROAR Score—developed by Rob Isbitts—offer ways to assess risk. Isbitts’ research, available on ETFYourself.com, helps individuals build balanced strategies without relying on financial advisors. XLV’s mix of stability, reasonable valuation, and broad healthcare exposure continues to draw interest. The fund’s defensive qualities stand out when tech stocks falter or markets turn rocky. With its diverse holdings and historically smooth performance, it remains a key option for cautious investors.